Biologic Abatement and Capturing Kids’ Outcomes and Flare Frequency in Juvenile Spondyloarthritis (BACK-OFF JSpA): study protocol for a randomized pragmatic trial

Abstract Background The effectiveness of biologic therapies, primarily tumor necrosis factor inhibitors (TNFi), for children with spondyloarthritis (SpA) has made inactive disease a realistic patient outcome. However, biologic therapies are costly, primarily delivered by subcutaneous or intravenous...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Pamela F. Weiss, Cora E. Sears, Timothy G. Brandon, Christopher B. Forrest, Emily Neu, Melanie Kohlheim, Jenny Leal, Rui Xiao, Daniel Lovell
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2023-02-01
Schriftenreihe:	Trials
Schlagworte:	Spondyloarthritis Pediatrics Biologic Randomized pragmatic trial Electronic Health Records Patient-reported outcome
Online-Zugang:	https://doi.org/10.1186/s13063-022-07038-6
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!